Görkem Garipler is a Senior Scientist at Conception Bio, focusing on the development of novel technologies for stem cell differentiation into human eggs. Previously, they played a crucial role at Patch Biosciences, where they contributed to its acquisition by Ginkgo Bioworks and led interdisciplinary teams in innovative gene therapy projects. Görkem's academic background includes a Ph.D. in Biology from New York University, where they designed a transcription factor-wide CRISPR screen and established essential embryonic stem cell lines. They have a keen interest in genome engineering technology and cell differentiation.
This person is not in any teams
This person is not in any offices